Showing results (31-40 of 46) with videos related to
Sort By:
Pageof 5
Molecules (Basel, Switzerland)|April 9, 2020
A Pilot Study on the Effect of Anti-Thrombopoietin Antibody on Platelet Count in Patients with Type 2 DiabetesTakuya Fukuda, Masahide Hamaguchi, Takafumi Osaka, et al.Cancer Science|December 12, 2019
Promotion of the Warburg effect is associated with poor benefit from adjuvant chemotherapy in colorectal cancerMasashi Kitazawa, Tomohisa Hatta, Yusuke Sasaki, et al.Heliyon|August 16, 2021
Massive surge of mRNA expression of clonal B-cell receptor in patients with COVID-19Yohei Funakoshi, Goh Ohji, Kimikazu Yakushijin, et al.British Journal of Cancer|June 25, 2026
Circulating tumor-associated autoantibody signatures for diagnosis and prognosis in small-cell lung cancer and lung adenocarcinomaChaoqi Liu, Eriko Fukuda, Yoji Sagiya, et al.Asian Pacific Journal of Cancer Prevention : APJCP|December 3, 2015
Serum Anti-Gal-3 Autoantibody is a Predictive Marker of the Efficacy of Platinum-Based Chemotherapy against Pulmonary AdenocarcinomaKengo Yanagita, Ryo Nagashio, Shinichiro Ryuge, et al.Anticancer Research|December 1, 2017
Analysis of Autoantibodies Related to Tumor Progression in Sera from Patients with High-grade Non-muscle-invasive Bladder CancerSho Minami, Kazumasa Matsumoto, Ryo Nagashio, et al.The American Journal of Pathology|May 13, 2018
Cytoskeleton-Associated Protein 4 Is a Novel Serodiagnostic Marker for Lung CancerKengo Yanagita, Ryo Nagashio, Shi-Xu Jiang, et al.Pathology International|February 13, 2018
Basigin expression as a prognostic indicator in stage I pulmonary adenocarcinomaToshihide Matsumoto, Ryo Nagashio, Shinichiro Ryuge, et al.Lung Cancer (Amsterdam, Netherlands)|September 8, 2015
Calnexin is a novel sero-diagnostic marker for lung cancerMakoto Kobayashi, Ryo Nagashio, Shi-Xu Jiang, et al.Nature Methods|March 8, 2017
A large-scale targeted proteomics assay resource based on an in vitro human proteomeMasaki Matsumoto, Fumiko Matsuzaki, Kiyotaka Oshikawa, et al.Pageof 5